Phathom Pharmaceuticals, Inc. Common Stock
PHAT Real Time Price USDRecent trades of PHAT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PHAT's directors and management
Government lobbying spending instances
-
$15,000 Apr 21, 2025 Issue: Health Issues
-
$10,000 Apr 19, 2021 Issue: Health Issues
Estimated quarterly lobbying spending
PHAT Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to PHAT
Recent picks made for PHAT stock on CNBC
| Personality | Type | Date |
|---|---|---|
| Jim Cramer | Sell | 10/12/2023 |
| Jim Cramer | Speculative | 05/03/2023 |
ETFs with the largest estimated holdings in PHAT
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $PHAT stock a Buy, Sell, or Hold?
- What is the price target for $PHAT stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $PHAT stock?
- Who owns the most shares of $PHAT stock?
- What funds own $PHAT stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PHAT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.